UBS’s Cel-Sci Corp Series S CVM.WS Stock Holding History

UBS’s Portfolio CVM.WS Stock Details CVM.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,100	Closed	-$1K	–	11024
2014 Q2	$1K	Buy	+3,100	New	+$885	﹤0.01%	10282

Other funds holding CVM.WS

FNYS

First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS's CVM.WS Position: Q3 2014 in Review

UBS sold out of Cel-Sci Corp Series S (CVM.WS) in Q3 2014, closing a stake of 3,100 shares — an estimated $1K sold.

UBS first reported a position in CVM.WS in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 5 funds tracked by Wall St. Rank hold CVM.WS as of Q3 2014.

UBS reported no remaining Cel-Sci Corp Series S position as of Q3 2014 after selling out during the quarter.
UBS sold 3,100 Cel-Sci Corp Series S shares in Q3 2014, an estimated $1K.
UBS first reported a position in Cel-Sci Corp Series S in Q2 2014 and held it in 1 quarter.
UBS's Cel-Sci Corp Series S position peaked at $1K in Q2 2014.
5 funds tracked by Wall St. Rank held Cel-Sci Corp Series S as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.